Trials / Completed
CompletedNCT02335502
A Post Market Study to Assess the Spinal Modulation Neurostimulator System for Chronic Intractable Pain
A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Intractable Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 66 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
04-SMI-2012 is post market, observational, questionnaire based study to assess the effectiveness of the commercially available Axium neurostimulator in the management of chronic, intractable pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantation with the commercially available Axium neurostimulator |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-06-01
- Completion
- 2015-07-01
- First posted
- 2015-01-09
- Last updated
- 2019-02-04
- Results posted
- 2017-08-03
Locations
2 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02335502. Inclusion in this directory is not an endorsement.